Edition:
United States

Vectura Group PLC (VEC.L)

VEC.L on London Stock Exchange

79.05GBp
16 Feb 2018
Change (% chg)

1.35 (+1.74%)
Prev Close
77.70
Open
78.10
Day's High
80.25
Day's Low
77.05
Volume
3,261,421
Avg. Vol
4,037,516
52-wk High
166.97
52-wk Low
70.50

Select another date:

Thu, Jan 4 2018

BRIEF-Vectura Group Anticipates FY 2017 Revenue In Line With Board's Expectations

* FULL YEAR 2017 REVENUE ANTICIPATED TO BE IN LINE WITH BOARD'S EXPECTATIONS

BRIEF-Vectura group announces buyback to return up to £15 million of capital to shareholders​

* ‍vectura group plc (lse: vec) ("vectura", " group"), announces that board has approved a share buyback to return up to £15 million of capital to shareholders​ Source text for Eikon: Further company coverage: (Reporting by Lawrence White)

BRIEF-Vectura confident on outlook for Novartis inhaler products

* Q3 2017 net sales of $101 million for ultibro ® breezhaler ® and $37 million for seebri ® breezhaler​

BRIEF-Vectura updates on positive Flutiform K-haler regulatory progress

* ‍FLUTIFORM BREATH-ACTIVATED K-HALER MAKES POSITIVE EUROPEAN REGULATORY PROGRESS​

BRIEF-Vectura Group posts HY revenue of 78.8 million pounds

* HY REVENUE 78.8 MILLION POUNDS VERSUS 73.9 MILLION POUNDS A YEAR AGO

BRIEF-Vectura signs VR410 agreement with Pulmatrix

* PROGRESSING DEVELOPMENT OF BRANDED GENERIC TIOTROPIUM BROMIDE PROGRAMME (VR410) FOR US MARKET, ACCELERATED THROUGH LICENCE DEAL WITH PULMATRIX

Select another date: